InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Clowes Howard, 董事. Officer active across 1 company, notably Plus Therapeutics, INC.. In total, 7 reports have been logged. Split: 6 buys · 0 sell. Total volume traded: €54k. Activity tracked since 2 June 2022. The latest transaction was disclosed on 11 September 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Howard Clowes is a Board Member at PLUS THERAPEUTICS, INC. He brings expertise in business management and growth strategies. His role as a board member involves overseeing the company's operations and contributing to strategic decision-making. Howard is committed to ensuring compliance and promoting best governance practices within the organization.